$0.315
0.010 (3.28%)
|
High $0.32 |
Low $0.30 |
Trades 243 |
Turnover $627,825 |
Volume 2,012,212 |
| 30 June 2023 at 4:10pm | ||||
IMMUTEP LIMITED
Pharmaceuticals, Biotechnology & Life Sciences
|
Market Cap (14-Nov) $36,843,036 (530th) |
Close (30-Jun) $0.315 |
Volume (30-Jun) 2,012,212 |
Shortsold (9-Nov) 20,215,263 (1.37%) (219th) |
|
52w High $0.470 |
52w Low $0.020 |
P/E 7.20 |
EPS -0.05 |
[ARTICLE] Small cap biotech Immutep soars 10.5pc on Merck deal
A news article has been posted about Immutep on the AFR. The article was published around , on 16 March 2021 at 5:43pm.
Immutep has signed another deal with Merck to test its immunotherapy drug alongside Merck’s multibillion dollar therapy Keytruda.
Read ArticleIMM was $0.37 at the close of trade on 16 March 2021
Find all articles about Immutep, including others on the AFR, on the media page.
If you were already registered, log in here.
If you were already registered, log in here.